Pilot 99mTechnetium-MIBI Single Photon Emission Computed Tomography - Computed Tomography (SPECT-CT) in Papillary Carcinoma (CA) Thyroid

99mTechnetium-MIBI SPECT-CT for Pre-operative Evaluation of Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma; A Pilot Study

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00984191

Enrollment

Registered

2009-09-25

Start date

2010-03-31

Completion date

2011-11-30

Last updated

2011-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Papillary Thyroid Cancer

Keywords

Papillary thyroid cancer, 99mTechnetium MIBI SPECT CT, preoperative, cervical lymphadenopathy, cervical metastasis

Brief summary

The purpose of this trial is to see if the 99mTechnetium-MIBI SPECT-CT can be a tool for preoperative evaluation of cervical node metastasis in papillary thyroid cancer.

Interventions

RADIATION99mTc-MIBI SPECT-CT

99mTc-MIBI SPECT-CT for abnormal cervical lymph node

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

DIAGNOSTIC

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* papillary thyroid cancer

Exclusion criteria

* pregnancy * Bleeding abnormality * Prior history of head and neck cancer * can not perform 99mTechnetium-MIBI SPECT-CT * can not perform 131I remnant Ablation * Prior any head and neck surgery within 3 months * Prior deep neck infection within 3 months

Design outcomes

Primary

Measure	Time frame
Diagnostic Tool Statistic (PPV , NPV , Sensitivity , Specificity , Accuracy )	18 months

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026